Could a migraine pill stop dizziness in an hour?
NCT ID NCT07435090
Summary
This study is testing whether rimegepant, a medication approved for migraines, can safely and effectively treat sudden, severe dizziness attacks. It will involve about 370 adults who experience recurrent dizziness episodes often linked to migraine-like symptoms. Researchers will measure how many people feel much better within one hour of taking the medication and will also check blood levels of a protein (CGRP) to see if it predicts who responds best.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIZZINESS are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.